← Open Payments lookup

ALLA IOSPA: Open Payments

NPI 1710058896 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,942 in 64 payments from 13 companies in 2025. Trend: 2023 $476 · 2024 $699 · 2025 $1,942

Food & beverage: $1,843Education: $100
CompanyPaymentsAmount
ABBVIE INC.12$383
Axsome Therapeutics, Inc.8$351
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$335
Otsuka America Pharmaceutical, Inc.10$242
Teva Pharmaceuticals USA, Inc.4$155
Alkermes, Inc.7$153
Takeda Pharmaceuticals U.S.A., Inc.5$98
Vanda Pharmaceuticals Inc.2$68
Supernus Pharmaceuticals, Inc.2$46
E.R. Squibb & Sons, L.L.C.1$37

Products named: VRAYLAR, Auvelity, CAPLYTA, REXULTI, TRINTELLIX, LYBALVI, FANAPT, ARISTADA.

Industry payments across NY — which companies pay providers there.